RVMD vs PAYX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RVMD · Revolution Medicines$192.28 ▲ 8.24%
PAYX · Paychex$117.06 ▼ 2.04%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RVMD +206.5%
- PAYX +8.6%
Head to head
| Metric | RVMD | PAYX |
|---|---|---|
| Price | $192.28 | $117.06 |
| Change today | ▲ 8.24% | ▼ 2.04% |
| Market cap | $41.59B | $41.67B |
| Return, 3 months | -7.1% | -3.4% |
| Return, year to date | +141.4% | +7.9% |
| Return, 1 year | +215.2% | +8.1% |
| P/E (TTM) | – | 23.2 |
| P/B | 17.3 | 11.2 |
| P/E percentile vs own 5y | 11th | 12th |
| Dividend yield | – | 3.88% |
| Revenue growth (YoY, latest qtr) | – | +5.9% |
| Net profit growth (YoY) | -160.1% | +12.0% |
| Gross margin | – | 74.4% |
| Operating margin | – | 39.2% |
| Net margin | – | 27.4% |
| Return on equity | -79.1% | 47.1% |
| Analyst target vs. price | +40.6% | -0.1% |
| Analyst buy share | 100% | 7% |
| RSI (14) | 50 | 59 |
| 30-day volatility | 61.1% | 33.4% |
| Max drawdown, 1 year | -25.0% | -30.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PAYX is the largest of the group by market value.
- RVMD has returned the most over the past year.
- PAYX has been the calmest stock over the last 30 days.